ghk cu peptide injection prescription GHK-Cu Injectable GHK-Cu 50mg | PeptideX Research

TP73 increases by 938%, while USP29 (which stabilizes p53) increases by 1,056%

DSIP-CBBBP fusion peptide and DSIP treatments demonstrated even more significant increases in neuron density compared to the model group, emphasizing the potential of these treatments in counteracting neuronal loss associated with insomnia

Analytical Identity Copper Tripeptide-1 (GHK-Cu, CAS 89030-95-5) is a naturally occurring copper-binding tripeptide - glycyl-L-histidyl-L-lysine chelated to a divalent copper ion (Cu2+) - first identified in human plasma, where its concentration has been reported to decline with age, and later characterized in saliva and other biological fluids

10.1038/s42003-025-07738-0 21 LeaM.NourE.HilaD.ZaitY.ScharffY.Ben-YosefS.et al (2022)

Each vial contains 50mg of lyophilized GHK-Cu in a sealed 3mL glass vial, verified through Mile High Compounds three-tier quality protocol : 7x independent third-party analytical testing, 4-vial batch conformity verification, and comprehensive heavy metal screening

Clinical trials demonstrate that GHK-Cu skin serum can help reduce the effects of UV radiation